VEEV: AI Identifies Potential Call Buying Opportunity
AI-powered insights updated on 11/4/2025.
Trend
Above 50-day Moving Average ($285.66)
30- Day Change
Outperforming Industry Average (5.25% vs 0.21%)
Historical Volatility
Moderate (25.64%)
VEEV Earnings Date & Key Events
| Date | Event | Type |
|---|---|---|
| 11/20/2025 | VEEV Earnings | VEEV-Specific |
Full Analysis Breakdown
Veeva is a leading provider of industry cloud solutions for the global life sciences industry. Its offerings include cloud software, data, and business consulting. The company's solutions are grouped into four major product categories: 'Veeva Development Cloud', 'Veeva Quality Cloud', 'Veeva Commercial Cloud', and 'Veeva Data Cloud'. 'Veeva Development Cloud' includes application suites for clinical, regulatory, and safety functions, while 'Veeva Commercial Cloud' offers solutions for sales, marketing, and medical affairs. 'Veeva Data Cloud' is a modern data platform with connected reference, deep, and transaction data. Veeva targets pharmaceutical, biotechnology, and medical device companies, as well as contract research organizations. Veeva differentiates itself by providing targeted solutions that quickly adapt to regulatory changes, incorporating relevant enhancements to existing solutions, and offering a unique, in-depth perspective into the needs and best practices of life sciences companies.
No relevant news was found for this stock today.
VEEV's technical outlook is cautiously optimistic. The recent price action shows a recovery from a low in late October. The closing price of $293.50 is above the 50-day SMA of $285.49 and the 21-day EMA of $289.93, indicating short-term bullish momentum, although the price has recently decreased from the high of $306.22 from early October. The MACD is showing a potential shift; while the MACD line is above the signal line, indicating bullish momentum, the MACDh is negative, which could indicate a weakening trend. The RSI at 53.71 is neutral, not strongly indicating overbought or oversold conditions. The Stochastic Oscillator shows the %K line at 57.37 and the %D line at 48.18, suggesting a potential for further upside if the %K line continues to rise above %D. Overall, the technical indicators suggest a moderately bullish outlook, contingent on the price maintaining above its short-term moving averages and a positive crossover in MACD.
Veeva Systems' MD&A presents a positive growth trajectory. Total revenues for the three months ended July 31, 2025, increased by 17% to '$789.081 million', with subscription services revenue driving the growth, up 17% to '$659.183 million'. The gross margin remained stable at '75%'. For the six months ended July 31, 2025, net cash provided by operating activities increased to '$1,115.591 million' from '$856.390 million' in the prior year, reflecting increased sales and the impact of the One Big Beautiful Bill Act ('OBBBA'). The company anticipates that cash flows from operating activities will be substantially less in the subsequent quarters. Veeva expects cost of subscription services to increase in absolute dollars in the future due to increased usage and investment in data solutions, and operating expenses are also expected to increase, 'primarily due to employee compensation-related costs'. The company believes its existing cash, cash equivalents, and short-term investments will be sufficient to meet its working capital and capital expenditure needs over at least the next 12 months.
Veeva Systems Inc.'s Q2 earnings call projects a moderately bullish outlook, buoyed by strong performance and strategic advancements. CEO Peter Gassner highlighted 'another strong quarter delivering Q2 results ahead of our guidance,' with total revenue at $789 million. A key development is the resolution of the long-standing dispute with IQVIA, which Gassner believes unlocks significant opportunities in the commercial area. He noted that 'historically, in the commercial area, there were two barriers...Now that's gone.' This resolution allows Veeva Systems Inc. to fully integrate IQVIA data into its Veeva Network and Nitro offerings. CFO Brian Van Wagener raised the full-year billings guidance by $35 million, emphasizing that 'annual is the better indicator.' While Veeva AI is still in its early stages, management is excited about its transformative potential, though anticipating no material revenue contribution until fiscal '26 or '27. The company also reported seven top 20 customers committed to Vault CRM, increasing to nine with verbal commitments, signaling strong market adoption and confidence in Veeva Systems Inc.'s CRM solutions.
VEEV's financial performance indicates a moderately positive trajectory. Revenue has steadily increased from $616.5M in Q3 2023 to $789.1M in Q2 2025, demonstrating consistent top-line growth. The gross profit ratio has remained relatively stable, fluctuating between 0.72 and 0.77, with the most recent quarter showing a ratio of 0.75. Operating cash flow is generally positive, with the latest quarter reporting $238.4M, although it has fluctuated significantly over the observed period. Total debt shows a slight increase from $57.7M in Q3 2023 to $85.4M in Q2 2025, but the company maintains a substantial net debt position of -$1.84B, indicating a strong cash reserve relative to its debt. Overall, VEEV exhibits healthy revenue growth, stable profitability, and strong cash flow, suggesting a positive outlook for the next 6-12 months.
The company presents a moderately bullish investment profile based on its key metrics and financial ratios. Revenue has shown positive growth, indicating a healthy demand for its products or services. The gross margin has remained relatively stable, suggesting efficient cost management. The Return on Equity (ROE) indicates a solid return for shareholders. The Price-to-Earnings (P/E) ratio suggests the company is appropriately valued by the market. The debt-to-equity ratio has seen a decrease, showcasing the company's improved financial leverage. The current ratio signifies the company's strong ability to meet its short-term obligations. Overall, the company demonstrates a stable and growing business model with a healthy balance sheet, making it a moderately attractive investment for the next 6-12 months.
The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any security should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.